Qvella Corporation
Qvella was founded with a vision to enable faster clinical decisions for better patient outcomes in sepsis diagnosis by reducing time to actionable results. Qvella’s FAST-Technology™ (Field Activated Sample Treatment) facilitates automation and acceleration of different stages of microbiology workflow to generate actionable information for bloodstream infections in minutes. Today, Qvella’s focus is to bring two unique products to the market. The FAST-Prep™ PBC System* automated system is designed to isolate and concentrate viable bacterial cells directly from a positive blood culture, yielding a clean Liquid Colony™ in ~30 minutes, which is ready-to-use for multiple downstream applications. The FAST-ID™ BSI System* is designed for fully automated pathogen isolation and detection including Candida, Gram negative and positive bacteria from whole blood in minutes instead of hours or days. *FAST-Prep PBC System and the FAST-ID BSI System are in development and not approved for sale.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes